Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Third Quarter Fiscal 2010

LAIYANG, China, May 13 JiangboPharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company" or "Jiangbo"),a pharmaceutical company with its principal operations in China, todayannounced that the Company will host a conference call at 7:00 a.m. EasternTime on Monday, May 17, 2010 to discuss financial results for the thirdquarter fiscal 2010 ended March 31, 2010.

The conference call will be hosted by Mr. Wubo Cao, Chairman and CEO, andMs. Elsa Sung, CFO, of Jiangbo.

To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time: (877)762-9219. International callers should dial +1 (706) 758-5465. The ConferenceID for this call is 74532345.

If you are unable to participate on the liver call, a replay will beavailable for 14 days starting on Monday, May 17, 2010 at 9:00 a.m. EasternTime. To access the replay, dial (800) 642-1687, international callers dial(706) 645-9291. Conference ID is 74532345.

About Jiangbo Pharmaceuticals, Inc.

Jiangbo Pharmaceuticals is engaged in the research, development,production, marketing and sales of pharmaceutical products in China. TheCompany's operations are located in Eastern China in an Economic DevelopmentZone in Laiyang City, Shandong Province. Jiangbo produces both western andChinese herbal-based medical drugs in tablet, capsule, granule, syrup andelectuary (sticky syrup) form. For additional information, please visit theCompany's website (http://www.jiangbopharma.com ).For more information, please contact: Jiangbo Pharmaceuticals, Inc. Ms. Elsa Sung, CFO Phone: +1-954-727-8435 Email: [email protected] http://www.jiangbopharma.com CCG Investor Relations, Inc. Ms. Lei Huang, Account Manager Phone: +1-646-833-3417 Email: [email protected] Web: http://www.ccgirasia.com Mr. Crocker Coulson, President Phone: +1-646-213-1915 Email: [email protected]

SOURCE Jiangbo Pharmaceuticals, Inc.